These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23597195)

  • 1. Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents.
    Wang Y; Li Y; Liu X; Cho WC
    Curr Cancer Drug Targets; 2013 Jun; 13(5):506-18. PubMed ID: 23597195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.
    Qian B; Nag SA; Su Y; Voruganti S; Qin JJ; Zhang R; Cho WC
    Curr Cancer Drug Targets; 2013 Jun; 13(5):519-41. PubMed ID: 23597193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer chemoprevention by targeting the epigenome.
    Huang J; Plass C; Gerhauser C
    Curr Drug Targets; 2011 Dec; 12(13):1925-56. PubMed ID: 21158707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in translational pharmacological investigations in identifying and validating molecular targets of natural product anticancer agents.
    Yu J; Nag SA; Zhang R
    Curr Cancer Drug Targets; 2013 Jun; 13(5):596-609. PubMed ID: 23597194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Compounds: Role in Reversal of Epigenetic Changes.
    Aggarwal R; Jha M; Shrivastava A; Jha AK
    Biochemistry (Mosc); 2015 Aug; 80(8):972-89. PubMed ID: 26547065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural products in the reprogramming of cancer epigenetics.
    Irshad R; Husain M
    Toxicol Appl Pharmacol; 2021 Apr; 417():115467. PubMed ID: 33631231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
    Jankowska AM; Millward CL; Caldwell CW
    Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer epigenetics: Moving forward.
    Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
    PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome.
    Khan SI; Aumsuwan P; Khan IA; Walker LA; Dasmahapatra AK
    Chem Res Toxicol; 2012 Jan; 25(1):61-73. PubMed ID: 21992498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dietary polyphenols in alternating DNA methylation in cancer.
    Qadir Nanakali NM; Maleki Dana P; Sadoughi F; Asemi Z; Sharifi M; Asemi R; Yousefi B
    Crit Rev Food Sci Nutr; 2023 Nov; 63(33):12256-12269. PubMed ID: 35848113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting miRNAs by natural products: A new way for cancer therapy.
    Zhang B; Tian L; Xie J; Chen G; Wang F
    Biomed Pharmacother; 2020 Oct; 130():110546. PubMed ID: 32721631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cancer molecular targets of natural products.
    Zi X; Zhang R
    Curr Cancer Drug Targets; 2013 Jun; 13(5):485. PubMed ID: 23802843
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways.
    Lernoux M; Schnekenburger M; Dicato M; Diederich M
    Pharmacol Res; 2018 Mar; 129():337-356. PubMed ID: 29133216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy.
    Maio M; Covre A; Fratta E; Di Giacomo AM; Taverna P; Natali PG; Coral S; Sigalotti L
    Clin Cancer Res; 2015 Sep; 21(18):4040-7. PubMed ID: 26374074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of microRNAs by natural agents: new strategies in cancer therapies.
    Phuah NH; Nagoor NH
    Biomed Res Int; 2014; 2014():804510. PubMed ID: 25254214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modulators from "The Big Blue": a treasure to fight against cancer.
    Schnekenburger M; Dicato M; Diederich M
    Cancer Lett; 2014 Sep; 351(2):182-97. PubMed ID: 24964131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and potential anticancer drugs targeting members of the UHRF1 complex including epigenetic modifiers.
    Unoki M
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):116-30. PubMed ID: 21110828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
    Hanikoglu A; Hanikoglu F; Ozben T
    Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Products and Chemical Biology Tools: Alternatives to Target Epigenetic Mechanisms in Cancers.
    Lascano S; Lopez M; Arimondo PB
    Chem Rec; 2018 Dec; 18(12):1854-1876. PubMed ID: 30537358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy-associated targeting pathways of natural products during cancer treatment.
    Zhang SF; Wang XL; Yang XQ; Chen N
    Asian Pac J Cancer Prev; 2014; 15(24):10557-63. PubMed ID: 25605139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.